• Evaluating the Benefits and Risks of Weight Loss Drugs

    Apr 03 | Bio-IT World| Weight loss medications are in “skyrocketing” utilization. Yet there have been no comprehensive investigations or studies on the effectiveness and risks of glucagon-like peptide-1 receptor agents (GLP-1RA). Researchers at the WashU Medicine collaborated with the Veterans Affairs (VA) St. Louis Health Care System to examine and evaluate more than two million people with diabetes taking popular weight loss drugs such as Ozempic. More

  • Large Genetic Study Further Untangles the Height-Health Connection

    Apr 02 | Bio-IT World| In the largest phenome wide association study across diverse population groups, an international team of researchers have identified 254 statistically significant associations between genetically explained height and various diseases. Genetically predicted height was linked with decreased risk of 90 diseases and increased risk of 164 others, most notably atrial fibrillation, and a series of conditions involving mental health and the endocrine system that have not been previously described. More

  • Bio-IT World Best of Show Finalists Named

    Mar 28 | Bio-IT World| Finalists have been named for the 2025 Bio-IT World Best of Show Awards program. More than 20 new products will be on display next week at the Bio-IT World Conference & Expo. New products will be on display from Artificial, Boulder BioComputing, Copyright Clearance Center, Chemspace, Dantech Corporation, Discngine, expert.ai, Genomenon, Globus, GRAU DATA, iuvo, Komprise, Orchestra Bio, Quantum Corporation, QuartzBio, Sinequa, Tech Mahindra, TetraScience, The Hyve, and Velsera. More

  • Pistoia Alliance Reducing Carbon Footprint, Thermo Fisher Next-Gen Hybrid Capture Assay, More

    Mar 27 | Bio-IT World| The Pistoia Alliance launched the next phase of its project to measure and reduce the carbon footprint of clinical trials; the Lupus Research Alliance announced the inaugural recipients of the new Targeted Research Program on Engineered Cell Therapies for Lupus; and more. More

  • Follow the Money: Gene Editing Therapeutics, Breast Cancer AI Predictive Platform, More

    Mar 26 | Bio-IT World| Arbor Biotechnologies will advance its pipeline of novel gene editing therapeutics targeting diseases in the liver and central nervous system; Ataraxis AI will further the development of Ataraxis Breast, the world’s first AI-native prognostic/predictive platform for breast cancer; and more. More

  • Elsevier Launches AI Search, Summary, Comparison Tool for ScienceDirect

    Mar 20 | Bio-IT World| Last week, Elsevier launched ScienceDirect AI, a generative AI tool for researchers that will extract, summarize and compare trusted insights from millions of full-text articles and book chapters on ScienceDirect. More

  • Bio-IT World Names Innovative Practices Winners

    Mar 19 | Bio-IT World| Bio-IT World has named the 2025 Innovative Practices Awards winners, choosing to honor four entries. Winners this year include Genmab nominated by Genedata, NHS England nominated by IQVIA, Pistoia Alliance, and Regeneron. The judging panel also highlighted two entries for Honorable Mention: a separate entry from Pistoia Alliance and Quris-AI. More

  • Flatiron Health Enables Patient-Level Data Sharing Across National Borders

    Mar 18 | Bio-IT World| Patient-level real-world data (RWD) derived from harmonized electronic health records (EHRs) across four countries will help power multinational oncology research of the future, thanks to groundbreaking, collaborative efforts of Flatiron Health scientists working in the U.S., UK, Germany, and Japan. More

  • ‘Therapeutic Blood Clots’ Could Remedy Cartilage Loss from Osteoarthritis

    Mar 13 | Bio-IT World| Scientists at the University of Wisconsin – Madison believe it could soon be possible to use people’s own blood clots to treat bone-on-bone osteoarthritis by having the material be the scaffolding that fills the space where cushioning cartilage used to be. The plan is to have the clots serve as a temporary matrix that cells will infiltrate to be exposed to a gene that encourages them to form hyaline cartilage. More

  • New Healthcare Security Benchmark Highlights Key Investment Priorities and Risks

    Mar 12 | Bio-IT World| At a session in the Cybersecurity Pavilion of ViVE last month, Cormac Miller, President and CCO of Censinet, presented the company’s 2025 cybersecurity benchmark for the healthcare sector. This year’s benchmark revealed that for the third year in a row, organizations are focusing on respond and recover capabilities. More
View more articles
Bio IT World Lead Gen

 
Industry-spotlight

Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!

Industry-spotlight
Trends from the Trenches

Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!